MDCOY
10/8/26

PT Medco Energi Internasional Tbk (MDCOY)

Thursday
7:32 AM
ThesisThe recent strategic moves in expanding exploration rights and cost-cutting measures have improved investor sentiment towards Medco, suggesting potential for revenue growth.

Revenue Outlook

★ Analysts see FY2026 revenue reaching $2.8B — +17.1% growth in a single year.

Why Revenue Could Accelerate

  1. 01Medco's recent acquisition of additional exploration rights in East Kalimantan could increase production capacity by 15% over the next year.
  2. 02The company has implemented cost-cutting measures that are expected to reduce operational expenses by 10% in the next fiscal year.
  3. 03A recent partnership with a renewable energy firm could diversify Medco's revenue streams, targeting a 20% contribution from renewables by 2028.
  4. 04Recent geopolitical tensions in the Middle East have led to increased oil prices, benefiting Medco's revenue outlook.
  5. 05Transition to renewable energy sources
  6. 06Increased regional energy independence in Southeast Asia
  7. 07Fluctuations in WTI and Brent crude oil prices, impacting revenue and margins
  8. 08Changes in production volumes from key assets in Indonesia
FY2025 Snapshot
Revenue
$2.4B
NI Growth
-72.5%
EPS
$0.41

MDCOY Chart

6.46.66.76.97.07.00MDCOY Daily7.00May '26Jul '26Aug '26Oct '26

My Notes

  • "Management emphasized, 'Our focus on operational efficiency and strategic acquisitions positions us well for the future.'"
  • Moat: Medco's established presence in Indonesia and government relationships provide a durable competitive advantage.
  • value - the low price-to-earnings and price-to-book ratios suggest potential undervaluation, appealing to value-focused investors.
  • Higher interest rates could increase financing costs for capital-intensive projects…
  • Watch on earnings: WTI Crude Oil Price (DCOILWTICO), Brent Crude Oil Price (DCOILBRENTEU), Production volumes (boe/day).

One Sentence Summary:

The bull case is simple: analysts see revenue climbing from $2.8B to $2.7B as medco's recent acquisition of additional exploration rights in east kalimantan could increase production capacity by 15%.

Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.